171 related articles for article (PubMed ID: 22138203)
1. [Therapeutic compliance in patients with arterial hypertension and type 2 diabetes mellitus].
Gutiérrez-Angulo ML; Lopetegi-Uranga P; Sánchez-Martín I; Garaigordobil-Landazabal M
Rev Calid Asist; 2012; 27(2):72-7. PubMed ID: 22138203
[TBL] [Abstract][Full Text] [Related]
2. Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes.
Mateo JF; Gil-Guillén VF; Mateo E; Orozco D; Carbayo JA; Merino J
Int J Clin Pract; 2006 Apr; 60(4):422-8. PubMed ID: 16620354
[TBL] [Abstract][Full Text] [Related]
3. Determining the difference in medication compliance between the general patient population and patients receiving antihypertensive therapy: a case study.
Culig J; Leppée M; Boskovic J; Eric M
Arch Pharm Res; 2011 Jul; 34(7):1143-52. PubMed ID: 21811921
[TBL] [Abstract][Full Text] [Related]
4. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
5. Validity and reliability of a self-reported measure of medication adherence in patients with Type 2 diabetes mellitus in Singapore.
Wang Y; Lee J; Toh MP; Tang WE; Ko Y
Diabet Med; 2012 Sep; 29(9):e338-44. PubMed ID: 22672497
[TBL] [Abstract][Full Text] [Related]
6. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
Leenen FH; Wilson TW; Bolli P; Larochelle P; Myers M; Handa SP; Boileau G; Tanner J
Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
[TBL] [Abstract][Full Text] [Related]
7. Medication adherence affects treatment modifications in patients with type 2 diabetes.
Voorham J; Haaijer-Ruskamp FM; Wolffenbuttel BH; Stolk RP; Denig P;
Clin Ther; 2011 Jan; 33(1):121-34. PubMed ID: 21397778
[TBL] [Abstract][Full Text] [Related]
8. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A
Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes.
Bezie Y; Molina M; Hernandez N; Batista R; Niang S; Huet D
Diabetes Metab; 2006 Dec; 32(6):611-6. PubMed ID: 17296515
[TBL] [Abstract][Full Text] [Related]
10. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
Grant RW; Singer DE; Meigs JB
Clin Ther; 2005 Jun; 27(6):773-81. PubMed ID: 16117984
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].
Pérez A; González Blanco C; Hernández-Presa MÁ; Chaves J
Endocrinol Nutr; 2011; 58(6):283-90. PubMed ID: 21641286
[TBL] [Abstract][Full Text] [Related]
12. Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension.
van Onzenoort HA; Verberk WJ; Kessels AG; Kroon AA; Neef C; van der Kuy PH; de Leeuw PW
Am J Hypertens; 2010 Feb; 23(2):149-54. PubMed ID: 19927136
[TBL] [Abstract][Full Text] [Related]
13. [Arterial hypertension management in patients with type 2 diabetes].
Charpentier G; Genès N; Vaur L; Clerson P; Amar J; Guéret P; Cambou JP
Arch Mal Coeur Vaiss; 2002; 95(7-8):661-5. PubMed ID: 12365076
[TBL] [Abstract][Full Text] [Related]
14. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes.
Sakthong P; Chabunthom R; Charoenvisuthiwongs R
Ann Pharmacother; 2009 May; 43(5):950-7. PubMed ID: 19366872
[TBL] [Abstract][Full Text] [Related]
15. [Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill fixed-dose combinations for the treatment of hypertension].
Sicras Mainar A; Galera Llorca J; Muñoz Ortí G; Navarro Artieda R
Med Clin (Barc); 2011 Feb; 136(5):183-91. PubMed ID: 21106209
[TBL] [Abstract][Full Text] [Related]
16. The effect of an educational intervention on patients' knowledge about hypertension, beliefs about medicines, and adherence.
Magadza C; Radloff SE; Srinivas SC
Res Social Adm Pharm; 2009 Dec; 5(4):363-75. PubMed ID: 19962679
[TBL] [Abstract][Full Text] [Related]
17. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
Cooke CE; Lee HY; Tong YP; Haines ST
Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
[TBL] [Abstract][Full Text] [Related]
18. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F
G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043
[TBL] [Abstract][Full Text] [Related]
19. The effect of the content of the knowledge on adherence to medication in hypertensive patients.
Karaeren H; Yokuşoğlu M; Uzun S; Baysan O; Köz C; Kara B; Kirilmaz A; Naharci I; Pinar M; Yilmaz MB; Uzun M
Anadolu Kardiyol Derg; 2009 Jun; 9(3):183-8. PubMed ID: 19520651
[TBL] [Abstract][Full Text] [Related]
20. Medication adherence in hypertensive patients of different cardiovascular risk treated in primary health care.
Wiliński J; Dabrowski M
Przegl Lek; 2013; 70(6):377-80. PubMed ID: 24052973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
